| Year |
Citation |
Score |
| 2019 |
Matsumoto Y, Ishii M, Hasegawa S, Sekimizu K. Enterococcus faecalis YM0831 suppresses sucrose-induced hyperglycemia in a silkworm model and in humans. Communications Biology. 2: 157. PMID 31925042 DOI: 10.1038/s42003-019-0407-5 |
0.475 |
|
| 2019 |
Ishii M, Matsumoto Y, Katada T, Sekimizu K. Additive effects of Kothala himbutu (Salacia reticulata) extract and a lactic acid bacterium (Enterococcus faecalis YM0831) for suppression of sucrose-induced hyperglycemia in an in vivo silkworm evaluation system. Drug Discoveries & Therapeutics. 13: 133-136. PMID 31327788 DOI: 10.5582/Ddt.2019.01025 |
0.528 |
|
| 2019 |
Matsumoto Y, Ishii M, Hasegawa S, Sekimizu K. YM0831 suppresses sucrose-induced hyperglycemia in a silkworm model and in humans. Communications Biology. 2: 157. PMID 31069266 DOI: 10.1038/s42003-019-0407-5 |
0.48 |
|
| 2018 |
Ishii M, Matsumoto Y, Sekimizu K. Bacterial polysaccharides inhibit sucrose-induced hyperglycemia in silkworms. Drug Discoveries & Therapeutics. 12: 185-188. PMID 30146618 DOI: 10.5582/Ddt.2018.01040 |
0.505 |
|
| 2018 |
Ishii M, Matsumoto Y, Sekimizu K. Inhibitory effects of alpha-cyclodextrin and its derivative against sucrose-induced hyperglycemia in an in vivo evaluation system. Drug Discoveries & Therapeutics. 12: 122-125. PMID 29998992 DOI: 10.5582/Ddt.2018.01028 |
0.491 |
|
| 2018 |
Ishii M, Matsumoto Y, Sekimizu K. Estimation of lactic acid bacterial cell number by DNA quantification. Drug Discoveries & Therapeutics. 12: 88-91. PMID 29760341 DOI: 10.5582/Ddt.2018.01019 |
0.473 |
|
| 2017 |
Matsumoto Y, Ishii M, Shimizu K, Kawamoto S, Sekimizu K. [A Silkworm Infection Model to Evaluate Antifungal Drugs for Cryptococcosis]. Medical Mycology Journal. 58: E131-E137. PMID 29187715 DOI: 10.3314/mmj.17.016 |
0.451 |
|
| 2017 |
Ishii M, Matsumoto Y, Yamada T, Abe S, Sekimizu K. An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis. Scientific Reports. 7: 12289. PMID 28947778 DOI: 10.1038/S41598-017-12523-Z |
0.524 |
|
| 2017 |
Tabuchi F, Matsumoto Y, Ishii M, Tatsuno K, Okazaki M, Sato T, Moriya K, Sekimizu K. D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus. The Journal of Antibiotics. PMID 28588223 DOI: 10.1038/Ja.2017.56 |
0.494 |
|
| 2017 |
Nishida S, Ishii M, Nishiyama Y, Abe S, Ono Y, Sekimizu K. Lactobacillus paraplantarum 11-1 Isolated from Rice Bran Pickles Activated Innate Immunity and Improved Survival in a Silkworm Bacterial Infection Model. Frontiers in Microbiology. 8: 436. PMID 28373863 DOI: 10.3389/Fmicb.2017.00436 |
0.492 |
|
| 2017 |
Ishii M, Matsumoto Y, Nakamura I, Sekimizu K. Silkworm fungal infection model for identification of virulence genes in pathogenic fungus and screening of novel antifungal drugs. Drug Discoveries & Therapeutics. PMID 28228617 DOI: 10.5582/Ddt.2016.01080 |
0.516 |
|
| 2017 |
Ishii M, Matsumoto Y, Nishida S, Sekimizu K. Decreased sugar concentration in vegetable and fruit juices by growth of functional lactic acid bacteria. Drug Discoveries & Therapeutics. PMID 28202883 DOI: 10.5582/Ddt.2016.01079 |
0.506 |
|
| 2017 |
Ishii M, Nishida S, Kataoka K, Nishiyama Y, Abe S, Sekimizu K. Lactic acid bacteria of the Leuconostoc genus with high innate immunity-stimulating activity. Drug Discoveries & Therapeutics. PMID 28202882 DOI: 10.5582/Ddt.2016.01078 |
0.492 |
|
| 2017 |
Tabuchi F, Matsumoto Y, Ishii M, Tatsuno K, Okazaki M, Sato T, Moriya K, Sekimizu K. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus. The Journal of Antibiotics. PMID 28196977 DOI: 10.1038/Ja.2017.7 |
0.495 |
|
| 2016 |
Matsumoto Y, Ishii M, Sekimizu K. An in vivo invertebrate evaluation system for identifying substances that suppress sucrose-induced postprandial hyperglycemia. Scientific Reports. 6: 26354. PMID 27194587 DOI: 10.1038/Srep26354 |
0.53 |
|
| 2016 |
Matsumoto Y, Yasukawa J, Ishii M, Hayashi Y, Miyazaki S, Sekimizu K. A critical role of mevalonate for peptidoglycan synthesis in Staphylococcus aureus. Scientific Reports. 6: 22894. PMID 26961421 DOI: 10.1038/Srep22894 |
0.459 |
|
| 2016 |
Ishii M, Matsumoto Y, Sekimizu K. Usefulness of silkworm as a host animal for understanding pathogenicity of Cryptococcus neoformans. Drug Discoveries & Therapeutics. 10: 9-13. PMID 26902902 DOI: 10.5582/Ddt.2016.01015 |
0.508 |
|
| 2015 |
Ishii M, Matsumoto Y, Sekimizu K. Usefulness of silkworm as a model animal for understanding the molecular mechanisms of fungal pathogenicity. Drug Discoveries & Therapeutics. 9: 234-7. PMID 26370522 DOI: 10.5582/Ddt.2015.01052 |
0.519 |
|
| 2015 |
Ishii M, Matsumoto Y, Sekimizu K. Compounds in a particular production lot of tryptic soy broth inhibit Staphylococcus aureus cell growth. Drug Discoveries & Therapeutics. 9: 178-83. PMID 26193939 DOI: 10.5582/Ddt.2015.01030 |
0.486 |
|
| 2015 |
Inagaki Y, Matsumoto Y, Ishii M, Uchino K, Sezutsu H, Sekimizu K. Fluorescence imaging for a noninvasive in vivo toxicity-test using a transgenic silkworm expressing green fluorescent protein. Scientific Reports. 5: 11180. PMID 26061948 DOI: 10.1038/Srep11180 |
0.463 |
|
| 2015 |
Matsumoto Y, Ishii M, Hayashi Y, Miyazaki S, Sugita T, Sumiya E, Sekimizu K. Diabetic silkworms for evaluation of therapeutically effective drugs against type II diabetes. Scientific Reports. 5: 10722. PMID 26024298 DOI: 10.1038/Srep10722 |
0.498 |
|
| 2014 |
Matsumoto Y, Ishii M, Ishii K, Miyaguchi W, Horie R, Inagaki Y, Hamamoto H, Tatematsu K, Uchino K, Tamura T, Sezutsu H, Sekimizu K. Transgenic silkworms expressing human insulin receptors for evaluation of therapeutically active insulin receptor agonists. Biochemical and Biophysical Research Communications. 455: 159-64. PMID 25449269 DOI: 10.1016/J.Bbrc.2014.10.143 |
0.471 |
|
| Show low-probability matches. |